{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-164239","form_type":"8-K","ticker":"WLKP","cik":"0001604665","company_name":"Westlake Chemical Partners LP","filed_at":"2026-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.579115+00:00","generated_at":"2026-05-15T05:19:55.122849+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Westlake Chemical Partners appoints Jonathan Baksht as CFO effective June 15, 2026","bullets":["Jonathan H. Baksht appointed Senior Vice President and CFO of general partner, effective June 15, 2026.","Baksht most recently served as EVP and CFO of Fortune Brands Innovations from May 2025 to March 2026.","Prior CFO roles at Pactiv Evergreen Inc. (2022–2025) and Valaris Limited (2015–2021).","M. Steven Bender retires from board and transitions to Special Advisor to the President on June 15, 2026.","Baksht also appointed SVP and CFO of Westlake Corporation, the indirect parent company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-164239","json":"https://secwatch.observer/filing/0001193125-26-164239.json","markdown":"https://secwatch.observer/filing/0001193125-26-164239.md","text":"https://secwatch.observer/filing/0001193125-26-164239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604665/000119312526164239/0001193125-26-164239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604665/000119312526164239/d33835d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:19:55.122849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}